DNA METHYLATION PROFILE OF SELECTED CYTOKINES IN CYSTIC FIBROSIS
DOI:
https://doi.org/10.52340/jecm.2023.03.06Ключевые слова:
DNA, methylation profile, cytokines, Cystic FibrosisАннотация
Cystic fibrosis (CF) is the most common life-shortening autosomal recessive disorder in Caucasians with an incidence of about 1:3,000 live births. The gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein is found on the human chromosome 7 q31.2. CF is characterized by recurrent pulmonary infections, elevated sweat chloride, pancreatic and hepatic insufficiency, intestinal abnormalities, failure to thrive, diabetes, meconium ileus (MI) and other glandular defects. Chronic airway dysfunction and inflammation are the main cause of morbidity and mortality of patients. This inflammation is characterized by an increased production of pro-inflammatory cytokines in the lung. The aim of the presented study is to identify the methylation status of the promoters of inflammatory and anti-inflammatory cytokines (IL-8, TNFα IL-10) and quantitative analysis of these cytokines in cystic fibrosis patients. DNA methylation analysis of cytokine promoters was performed by the methylation-specific polymerase chain reaction. DNA fragments were amplified using specific primers for methylated or unmethylated DNA. Methylation analysis revealed statistically significant hypomethylation of IL-8 and TNFα gene promoter regions, whereas IL-10 gene promoter CpG sites were hypermethylated in cystic fibrosis patients compared to control individuals. In conclusion, identification of disease-modifying epigenetic factors at early stages of disease crucial for finding new therapeutic solutions and personalized approach in treatment of patients with Cystic Fibrosis.
Скачивания
Библиографические ссылки
Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC. (1989) Identification of the cystic fibrosis gene: genetic analysis. Science. Sep 8;245(4922):1073–1080.
Hartl D., Gaggar A., Bruscia E., Hector A., Marcos V., Jung A., Greene C., McElvaney G., Mall M., Döring G. (2012) Innate immunity in cystic fibrosis lung disease; J of Cystic Fibrosis. 11(5):363–382.
Farinha CM, Amaral MD. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol Cell Biol 2005; 25:5242-5252.
Khurtsilava I., Kvlividze O., Parulava Ts., Margvelashvili L. (2020) CFTR mutations and clinical manifestations in children diagnosed after neonatal screening. J. Exp and clinical medicine, 2:39-44.
Yaqin Xu and Stefan Worgall (2012). Immune Dysfunction in Cystic Fibrosis, Cystic Fibrosis - Renewed Hopes Through Research, Dr. Dinesh Sriramulu (Ed.), ISBN: 978-953-51-0287-8,
Courtney JM, Ennis M, Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros. 2004 Dec;3(4):223-31. doi: 10.1016/j.jcf.2004.06.006. PMID: 15698939.
Taggart C, Coakley RJ, Greally P, Canny G, O’Neill SJ, McElvaney NG. Increased elastase release by CF neutrophils is mediated by tumour necrosis factor-alpha and interleukin-8. Am J Physiol Lung Cell Mol Physiol 2000;278:L33–41.
Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815–22.
Magalhães, M., Rivals, I., Claustres, M. et al. DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis. Clin Epigenet 2017; 9:19.
Pineau F, Caimmi D, Taviaux S, Reveil M, Brosseau L, Rivals I, Drevait M, Vachier I, Claustres M, Chiron R, De Sario A. DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study. Genes. 2021; 12(3):441.
Ghughunishvili M., SurmavaS., Tkemaladze T., Gagua M., Abzianidze E., Kvaratskhelia E. DNA methylation profile in Cystic Fibrosis patients with C677T variant of MTHFR gene2020, European Journal of Human Genetics. 2020; 28:740-741.
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
